# Novo Nordisk has obtained approval for the pill form of its popular Wegovy anti-obesity drug.

*biotech · news · 2026-05-22 · Medical Xpress*

## Key points

- The EU has approved an oral version of Novo Nordisk's Wegovy anti-obesity drug for adults.
- Wegovy's pill is the first oral GLP-1 treatment available for weight management in the EU.
- The injectable form of Wegovy remains available for patients 12 and older, unlike the pill.
- Novo Nordisk expects to begin selling the oral drug in more markets in the second quarter.

**Companies:** Novo Nordisk
**Countries:** Denmark, United States, European Union

[Read the full story on Medical Xpress](https://medicalxpress.com/news/2026-05-eu-pill-novo-nordisk-wegovy.html)

---

Canonical: https://newsio.io/n/2b5fd9e0-c178-4e55-870b-fbca46c21cba/novo-nordisk-has-obtained-approval-for-the-pill-form-of-its-popular-wegovy-anti
Summarized by Newsio from Medical Xpress. https://newsio.io/how-it-works